BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25029513)

  • 21. Volume regression of native polycystic kidneys after renal transplantation.
    Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
    Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of total kidney volume in autosomal dominant polycystic kidney disease.
    Spithoven EM; van Gastel MD; Messchendorp AL; Casteleijn NF; Drenth JP; Gaillard CA; de Fijter JW; Meijer E; Peters DJ; Kappert P; Renken RJ; Visser FW; Wetzels JF; Zietse R; Gansevoort RT; ;
    Am J Kidney Dis; 2015 Nov; 66(5):792-801. PubMed ID: 26235803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.
    Lee YR; Lee KB
    Nephron Clin Pract; 2006; 103(4):c173-80. PubMed ID: 16636585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study.
    Woznicki P; Siedek F; van Gastel MDA; Dos Santos DP; Arjune S; Karner LA; Meyer F; Caldeira LL; Persigehl T; Gansevoort RT; Grundmann F; Baessler B; Müller RU
    Kidney360; 2022 Dec; 3(12):2048-2058. PubMed ID: 36591351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney volume and function in autosomal dominant polycystic kidney disease.
    Higashihara E; Nutahara K; Okegawa T; Shishido T; Tanbo M; Kobayasi K; Nitadori T
    Clin Exp Nephrol; 2014 Feb; 18(1):157-65. PubMed ID: 23864346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
    Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
    J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease.
    Suwabe T; Ubara Y; Oba Y; Mizuno H; Ikuma D; Yamanouchi M; Sekine A; Tanaka K; Hasegawa E; Hoshino J; Sawa N
    J Nephrol; 2023 May; 36(4):999-1010. PubMed ID: 36753000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
    Lai S; Mastroluca D; Letizia C; Petramala L; Perrotta AM; DiGaeta A; Ferrigno L; Ciccariello M; D'Angelo AR; Panebianco V
    Intern Med J; 2018 Dec; 48(12):1505-1513. PubMed ID: 30043487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.
    Sharma K; Caroli A; Quach LV; Petzold K; Bozzetto M; Serra AL; Remuzzi G; Remuzzi A
    PLoS One; 2017; 12(5):e0178488. PubMed ID: 28558028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.
    Jo WR; Kim SH; Kim KW; Suh CH; Kim JK; Kim H; Lee JG; Oh WY; Choi SE; Pyo J
    Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease.
    Higashihara E; Nutahara K; Okegawa T; Tanbo M; Hara H; Miyazaki I; Kobayasi K; Nitatori T
    Nephron; 2015; 129(4):253-62. PubMed ID: 25895545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
    Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
    Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease.
    Chen D; Ma Y; Wang X; Yu S; Li L; Dai B; Mao Z; Sun L; Xu C; Rong S; Tang M; Zhao H; Liu H; Serra AL; Graf N; Liu S; Wüthrich RP; Mei C
    PLoS One; 2014; 9(3):e92232. PubMed ID: 24651850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
    Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
    Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-contrast low-dose CT can be used for volumetry of ADPKD.
    Yoo J; Kim JU; Kim J; Jeon S; Song YJ; Choi KH; Kim SH; Yoon JW; Kim H
    BMC Nephrol; 2023 Oct; 24(1):317. PubMed ID: 37884882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy, Reproducibility and User Experience With Standardized Instructions for Measurement of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease.
    Bevilacqua M; Hague CJ; Romann A; Levin A
    Can Assoc Radiol J; 2023 May; 74(2):343-350. PubMed ID: 36063401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease.
    Bae KT; Tao C; Wang J; Kaya D; Wu Z; Bae JT; Chapman AB; Torres VE; Grantham JJ; Mrug M; Bennett WM; Flessner MF; Landsittel DP;
    Am J Nephrol; 2013; 38(4):333-41. PubMed ID: 24107679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
    King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
    Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
    Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.